Pricing

Log inSign up

Primmune Therapeutics

18 people · 0 jobs
‌

Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Their goal is to improve the response rate of patients to current and future immunotherapy medicines.

Industries

Biotechnology

Headquarters

San Diego, United States

Employees

1-10

Links

Org chart

Charles McDermott
Chairman, President & CEO
Collapse
Paulo Rangel
Chief Business Officer & Co-Founder
Curtis Scribner
Chief Medical Officer
Richard Daniels
Chief Operating Officer
James Appleman
SVP, R&D & CSO Co-Founder, Director

Board & advisors

Todd Harris
Director
Amir Nashat
Director
Andrew Rubinstein
Director
Isan Chen
Clinical Advisor
Ezra Cohen
Clinical Advisor
Sheldon Morris
Clinical Advisor
Elina Zuniga
Scientific Advisor
Jyoti Mayadev
Clinical Advisor
Tom Coll
Outside Counsel

Offices

Similar companies

Gilead Sciences

171 followers

Regeneron

144 followers

Illumina

81 followers

Agilent Technologies

89 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

49 followers

GRAIL

30 followers

Cytiva

19 followers

PerkinElmer

12 followers

Editas Medicine

5 followers

Organogenesis

5 followers

Explore companies